A highly specific enzyme-linked "sandwich" immunoassay is described for determining free human thyrotropin (hTSH) /3-subunit in serum by using a anti-hTSH /3-subunit monoclonal antibody conjugated with /3-o-galactosidase (EC 3.2.1.23) and a solid phase consisting of silicone rods coated with another monoclonal antibody. We could detect as little as 0.04 ng of /3-subunit per assay. The measurable range of hTSH /3-subunit concentrations in serum was 0.4 to 50 1ig/L. The assay demonstrated little or no cross reactivity with intact hTSH, hTSH a-subunit, or human choriogonadotropin. The mean CVs were 12.2% within assay, 13.9% between assay. The hTSH /3-subunit was not detectable in sera from healthy subjects, patients with hyperthyroidism, or two patients with pituitary tumors producing TSH. It was measurable (at concentrations of 0.65 to 2.70 1ig/L) in sera from eight of 23 hypothyroid patients. In five of the hypothyroid patients examined, the concentration of hTSH /3-subunit in serum increased after administration of thyroliberin. This method may be useful in elucidating the physiological and pathological significance of the hTSH /3-subunit and in examining the function of the hypothalamus-pituitary-thyroid axis. antibody to free hTSH /3and used it to establish a more highly specific immunoassay for hTSH /3.
The IgG fraction from mouse ascites was purified by precipitation with Na2SO4 (final concentration, 180 g/L) followed by chromatography on diethylaminoethyl-cellulose. unit of the hTSH used in this study corresponded to 0.2 pg of protein per liter.
We
We also tested the specificity of the assay as follows. A mixture of standard hTSH (0.8 pg) and hTSH f3 (1.85 pg) was passed through a 1 x 90cm column of Sephadex G-100 that had been pre-equilibrated with buffer A. Each fraction elutedwas examined by both the present EIA for hTSH /3
and an EIA specific for intact hTSH. The latter EIA is performed as follows. Into a test tube add 50 pL of hTSH standard or eluate, 50 RIA for hTSH in serum: TSH concentrations in sera from apparently healthy subjects and patients were measured with an RIA kit for hTSH (Daiichi Radioisotope Laboratories, Ltd., Tokyo, Japan).
TRH test: Five patients with primary hypothyroidism received 500 pg of synthetic TRH (Tanabe Seiyaku Co., Ltd., Tokyo, Japan) as an intravenous bolus. Their concentrations of hTSH /3in serum before and after this treatment were measured by the present EIA.
Subjects
Serum was sampled from 22 apparentlyhealthysubjects (12 men and 10 women, ages 24-38 years), 16 patients with hyperthyroidism (seven men and nine women, ages 21-54 years), 23 patients with primary hypothyroidism (11 men and 12 women, ages five to 62 years), and two patients with TSH-producing tumors (two women, ages 50 and 28 years). All serum samples were storedat -20 #{176}C until use. Repeated freeze-thawingwas avoided. Figure 1 illustrates a typical standard curve for assay of hTSH /3. The minimum concentration detectable was calculated to be 0.04 ng per assay by ascertaining (in 10 replicate determinations) the point where the 95% confidence limit of the response at zero dose intersected the standard curve. This corresponded to an hTSH . /3con- assay recognized an epitope on the free form of hTSH (3. Fig. 2 . Cross reactivity of EIA for hTSH . /3withpurified hTSH . /3(0)
Results

Standard curve:
The presentEIA cross reacted by as little as 0.07% with hTSH (#{149}), hTSH a (A), and hCG (U) hTSH and negligibly with hTSH a and hCG. Thus the Total assay volume,300 L. Points and bars represent means (±SD) tCr method is more specific for hTSH . /3 than are previous triplicate determinations methods (3, 4). In a previous RIA involving the use of polyclonal anti-hTSH . (3antibody, the cross reactivity with intact hTSH reportedly was 1% (3). Cross reactivity with intact hTSH is a particularly serious problem when serum samples contain high concentrations of intact hTSH, because the amount of serum hTSH /3isso much less than that of intact hTSH. For instance, using an assay system Figure 2 shows the cross reactivities of the present EIA for hTSH /3 with hTSH, hTSH a, and hCG. Intact hTSH at a concentration of 1250 pgfL showed an activity of bound enzyme corresponding to that observed with 0.9 pg of hTSH /3per liter, for a cross reactivity of 0.07%. The cross reactions with hTSH a and hCG were <0.03%.
In another experiment, we assayed eluates from gel chromatography of a mixture of intact hTSH and hTSH . /3.
As Figure 3 shows, both the present EIA for hTSH .13and
an ELk specific for intact hTSH yielded elution proffles with single peaks at different elution volumes: fractions 25-30 for hTSH and 35-40 for hTSH /3. The EIA for hTSH /3did not react with intact hTSH, even at its greatest concentration in the eluate. Each value was calculated from duplicate experi-
ments.
Analytical recovery: When hTSH /3 standards of 2.0 and 10 pg/L were added to three human sera containing <0.2, 2.4, and 4.0 pg of hTSH (3 per liter and assayed, the recoveries ranged from 79 to 100%. These values represent the means for duplicate experiments.
Assay stability and reproducibility: We checked the stability of intacthTSH in serum by determining, with this EIA, the amount of hTSH pin a pooled sample of human serum to which standard intact hTSH (500 pg/L) had been added. We observed no measurable change in the concentration of hTSH (3 for at least one month of storage at -20 #{176}C.
The reproducibility of the assay is shown in Table 1 . The within-assay CVs were 6.4 to 19.9% (mean 12.2%) and the between-assay CVs 9.8 to 18.8% (mean 13.9%) for serum samples stored at -20 #{176}C.
Serum concentrations of hTSH (3: The concentrations of hTSH /3 we determined by the present EIA in sera of healthy subjects and patients with thyroid diseases are as follows: No serum hTSH (3 was detectable in any of the healthy subjects or patients with hyperthyroidism that we examined. In these subjects, the serum hTSH concentrations measured by RIA were <8.0 mill-mt. units/L. In the two patients with TSH-producing tumors, who had serum hTSH of 16 (12) (13) (14) .
In the present study, we used another monoclonal antibody (B 10) as labeled antibody, which recognized a different epitope on hTSH' (3 from that recognized by Bi. Thus we could construct the present simultaneous two-site inimunometric assay. Furthermore, this monoclonal antibody had the highest affinity constant for hTSH /3of the eight clones of monoclonal anti-hTSH /3 antibodies obtained. This high affinity may contribute to the high sensitivity of the present EIA: 0.4 p.g/L, similar to or rather greater than those of previous RIAs (0.25-2.5 zgfL) (3, 4) .
In two-site immunometric assays involving two monoclonal antibodies, a common problem is a false increase in values for the antigen (8-11, 18 ). This phenomenon is usually attributable to the coexistence of heterophilic anti-
body-anti-mouse
IgG antibodies in human serum, which can react as a linker between solid-phase antibody and labeled antibody in the assay system. To avoid this effect of heterophilic antibody in the present assay system, we used a buffer containing mouse aseites, which contains a large amount of mouse IgG, to neutralize heterophilic antibody.
An in vitro stability test demonstrated that hTSH in But the concentration of hTSH /3and its detectability by the present EJA were both significantly lower than is true for previous RIAs. These differences may be attributable to the lower cross reactivity of the present EJA with other glycoprotein hormones, especially intact hTSH. These results suggest that the present EJA is useful for the precise measurement of hTSH (3 in human serum. The biological significance of free hTSH /3 in the circulation is unknown. The concentration of hTSH (3 in sera from patients with hypothyroidism determined by the present EIA correlated significantly with the intact hTSH in those sera (data not shown). This might suggest that the rate-limiting step in biosynthesis of hTSH in those patients is a step of a-(3 subunit association and that free hTSH (3, overproduced, leaks from the pituitary cell into the circulation.
We are now using this assay to examine a variety of clinical specimens and to elucidate the biological meaning of free hTSH /3 in the circulation.
